Platelets

Platelet Evaluation in Clinical Practice

  • Platelet evaluation is a common procedure in clinical practice, involving monitoring the number and functionality of platelets within a blood sample.

  • Video Resources:

    • Two video resources were recommended:
    • A short video that will be revisited in class.
    • A longer video (~50 minutes) for advanced understanding and easier concepts.

  • Presentation Overview:

    • The plan for the day includes:
    • Finishing the presentation.
    • Breaking into small groups for discussions.
    • Assisting with the posted homework assignment related to CVC (Complete Blood Count).

Understanding Platelets

  • Definition and Nature of Platelets:

    • Platelets are small cytoplasmic fragments produced in the bone marrow.
    • They play a critical role in blood clotting and hemostasis.
    • Common evaluation includes examining blood smears.

  • Common Challenges in Evaluation:

    • Automated analyzers may struggle with platelet counts due to:
    • Platelet clumping.
    • Enlarged platelets, often miscounted as white blood cells, particularly monocytes.

  • Terminology:

    • Thrombocytopenia: A decrease in platelet count.
    • Thrombocytosis: An increase in platelet count.

Platelet Counting Methods

  • Manual Platelet Count:

    • Best method for accurate evaluation.
    • A blood smear is prepared and observed.
    • Count platelets in 10 fields under oil immersion.
    • Average the count and multiply by 30,000 to estimate total platelet count.
    • Variations may exist in the multiplier depending on protocols across practices (confirm with instructors).

  • Platelet Characteristics to Observe:

    • Look for:
    • Platelet clumping (common in cats).
    • Size variations in platelets.
    • Reticulated platelets that have increased RNA content.

  • Platelet Count Estimates:

    • Direct Count: Count and multiply by a set number (30,000 or others as specified).
    • Indirect Count: Assess if the count is adequate by counting fields:
    • Adequate Count: 5-10 platelets per field.
    • Inadequate Count: 2-3 platelets per field.

  • Mean Platelet Volume (MPV):

    • The analyzer provides the MPV as a measure of average platelet size, which can indicate platelet loss due to:
    • Consumption.
    • Destruction (such as immune-mediated destruction).
    • Sequestration in the body.
    • High MPV can result from
    • Exposure to EDTA (anticoagulant).

  • Platelet Crit (PCV):

    • Indicates the percentage of blood volume occupied by platelets, normally <1%.
    • Blood components include red blood cells, plasma, and white blood cells.

Platelet Distribution and Function

  • Platelet Distribution Width (PDW):

    • Variability in platelet size analysis, generally not prioritized during diagnosis.

  • Platelet Function Tests:

    • Critical to assess platelet functionality:
    • A high platelet count with low functionality is as detrimental as low platelet counts.

Coagulation Testing Overview

  • Coagulation is the body’s ability to form clots through:

    • Mechanical Phase: Immediate response due to direct damage to blood vessels.
    • Chemical Phase: Involves multiple factors that facilitate clotting.

  • Key Factors in Coagulation:

    • Von Willebrand factor is essential for platelet adhesion to the endothelial layer of blood vessels.
    • Von Willebrand Disease: Common in Dobermans, creates issues in clot formation. Precaution is taken before surgeries for dogs with suspected conditions.

  • Coagulation Tests:

    • Intrinsic Pathway: Assessed using Activated Partial Thromboplastin Time (APTT).
    • Extrinsic Pathway: Assessed using Prothrombin Time (PT).
    • Clinical Significance: High values indicate hemophilia, liver disease, or other coagulation issues.

  • Important Tests Includes:

    • Buccal Mucosal Bleeding Time (BMBT):

    • Measures the time for a clot to form after a small incision in the buccal mucosa.

    • Normal time range: 1-5 minutes.

    • Used to assess platelet function and count adequacy.

    • Activated Clotting Time (ACT): This evaluates clotting but excludes factor VII.

    • Quick results are expected (under 1 minute is normal).

    • Clot Retraction Time: Measures the duration until a formed clot disappears; rarely used due to limited diagnostic utility.

    • Vitamin K Dependency: Factors II, VII, IX, and X are vitamin K dependent; vitamin K deficiency can result in inadequate clot formation.

    • Vitamin K replacement is crucial in cases of anticoagulant toxicity (e.g., rat poison).

Coagulation Disorders

  • Thrombocytopenia:

    • A frequent challenge in veterinary medicine, especially in cats due to larger and more clump-prone platelets.
    • Causes include:
    • Viral infections, bacterial infections, parasitic infections, and iatrogenic causes (medications).

  • Disseminated Intravasular Coagulation (DIC):

    • Abnormal clotting throughout the vascular system leading to a paradoxical risk of bleeding due to depletion of clotting factors.

  • Hereditary and Acquired Coagulation Disorders:

    • May include conditions like von Willebrand Disease, Hemophilia A, and others resulting from Vitamin K deficiencies or underlying diseases (such as liver and renal).

  • Symptoms to Note for Coagulation Disorders Include:

    • Petechia (bruising), epistaxis (nosebleeds), melena (digested blood), which indicate systemic clotting dysfunction.

  • Management of Coagulation Disorders:

    • Treatment may involve transfusion, administration of vitamin K, or addressing underlying health issues.

Conclusion

  • Recap of Important Tests for Coagulation and Platelet Evaluation:
    • Prioritize BMBT, PT, and PTT for determining hemostatic function.
    • Understand the significance of von Willebrand factor in clot formation.
    • Note that conditions vary greatly among species and require careful clinical evaluation and diagnostic testing for accurate assessment and treatment planning.